APM

Avidity Partners Management Portfolio holdings

AUM $499M
This Quarter Return
+23.63%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$4.28B
AUM Growth
+$4.28B
Cap. Flow
-$594M
Cap. Flow %
-13.88%
Top 10 Hldgs %
42.06%
Holding
115
New
18
Increased
32
Reduced
19
Closed
30

Top Buys

1
MDGL icon
Madrigal Pharmaceuticals
MDGL
$125M
2
UHS icon
Universal Health Services
UHS
$116M
3
SGRY icon
Surgery Partners
SGRY
$79.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$65.2M
5
PRTA icon
Prothena Corp
PRTA
$59.4M

Top Sells

1
LLY icon
Eli Lilly
LLY
$289M
2
BIIB icon
Biogen
BIIB
$160M
3
XBI icon
SPDR S&P Biotech ETF
XBI
$117M
4
HUM icon
Humana
HUM
$103M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
$98.4M

Sector Composition

1 Healthcare 99.55%
2 Financials 0.45%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SCYX icon
76
SCYNEXIS
SCYX
$34.9M
$1.78M 0.04%
1,140,600
– –
HYPR icon
77
Hyperfine
HYPR
$92.7M
$1.26M 0.03%
1,503,754
– –
FATE icon
78
Fate Therapeutics
FATE
$119M
$1.06M 0.02%
+104,653
New +$1.06M
ZLAB icon
79
Zai Lab
ZLAB
$3.75B
$961K 0.02%
31,309
-1,202,691
-97% -$36.9M
COLL icon
80
Collegium Pharmaceutical
COLL
$1.23B
$879K 0.02%
+37,898
New +$879K
ACIU icon
81
AC Immune
ACIU
$222M
$664K 0.01%
325,400
+50,524
+18% +$103K
REUN
82
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$504K 0.01%
560,300
-34,900
-6% -$31.4K
NUVB.WS icon
83
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$77.8M
$14.5K ﹤0.01%
99,999
– –
MSACW
84
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$5.2K ﹤0.01%
57,770
– –
ALNY icon
85
Alnylam Pharmaceuticals
ALNY
$59.2B
– –
-288,500
Closed -$57.7M
APLS icon
86
Apellis Pharmaceuticals
APLS
$3.54B
– –
-844,000
Closed -$57.6M
ATEC icon
87
Alphatec Holdings
ATEC
$2.33B
– –
-1,715,000
Closed -$15M
AVTR icon
88
Avantor
AVTR
$8.94B
– –
-4,522,600
Closed -$88.6M
BIIB icon
89
Biogen
BIIB
$21B
– –
-600,000
Closed -$160M
CNC icon
90
Centene
CNC
$14.5B
– –
-432,400
Closed -$33.6M
COGT icon
91
Cogent Biosciences
COGT
$1.83B
– –
-1,357,700
Closed -$20.3M
ELV icon
92
Elevance Health
ELV
$71.8B
– –
-207,600
Closed -$94.3M
ERAS icon
93
Erasca
ERAS
$406M
– –
-982,500
Closed -$7.66M
GOSS icon
94
Gossamer Bio
GOSS
$596M
– –
-1,450,000
Closed -$17.4M
HUM icon
95
Humana
HUM
$36.9B
– –
-212,000
Closed -$103M
IOVA icon
96
Iovance Biotherapeutics
IOVA
$807M
– –
-1,382,900
Closed -$13.2M
NKTX icon
97
Nkarta
NKTX
$154M
– –
-1,414,082
Closed -$18.6M
SIBN icon
98
SI-BONE Inc
SIBN
$702M
– –
-996,700
Closed -$17.4M
STOK icon
99
Stoke Therapeutics
STOK
$1.11B
– –
-891,100
Closed -$11.4M
SYK icon
100
Stryker
SYK
$149B
– –
-184,700
Closed -$37.4M
1 2 3
4
5